Results 191 to 200 of about 53,372 (298)

RSV Monoclonal Antibody Implementation for At‐Risk Infants: Victoria, Australia's 2024 Experience

Health Science Reports, Volume 9, Issue 9, September 2026.
ABSTRACT Background New respiratory syncytial virus (RSV) preventative programs are launching globally. Our Australian jurisdiction implemented RSV monoclonal antibody provision via pediatric and perinatal hospitals for highest risk neonates and infants.
Jane Tuckerman, Daryl R. Cheng, Guillian Hunter, Sonja Elia, Tara Hearn, Deepali Verma, Susan Jacobs, Jeremy Carr, Nigel W. Crawford   +8 more
wiley   +1 more source

Nasal Intermittent Positive Pressure Ventilation: Guideline Implementation Guided by Practice Preference Measurement. [PDF]

Pediatr Qual Saf
Gnecco-González S, Whitesel E, Zupancic J, Gupta M, Pursley DM, Healy H.   +5 more
europepmc   +1 more source

Incidence and Clinical Outcomes of Premature Infants: 1‐Year Retrospective Study at the NICU of Gadarif Teaching Hospital

Health Science Reports, Volume 9, Issue 9, September 2026.
ABSTRACT Background Prematurity remains a leading cause of neonatal morbidity and mortality worldwide, with the highest burden in low‐resource settings such as sub‐Saharan Africa. Reliable local data are limited in Sudan, particularly in Eastern states.
Mohammed Ahmed Abdellah Ahmed, Elshazaly Saeed, Elnazeir Mohamed Ibrahim Mohamedzain, Mohamed Salah Abdulrazeg Abdulrahman, Suleman Sofian Suliman, Ahmed Mohammed Ahmed Abdellah, A. L. Sir Ahmed Addalla Ahmed, Sohaib Mohammed Mokhtar Ahmed   +7 more
wiley   +1 more source

Optimizing CPAP Adherence in Obstructive Sleep Apnea: A Narrative Review of Practical Strategies for Everyday Clinical Care. [PDF]

Healthcare (Basel)
Antonaglia C, Fabozzi A, Steffanina A, Soave S, Confalonieri P, Nicolai A, Olmati F, Sanna A, Pena N, Ruaro B, Salton F, Bonini M, Confalonieri M, Palange P.   +13 more
europepmc   +1 more source

A Case of Cytokine Release Syndrome (CRS) Related to Treatment With Lenvatinib Plus Pembrolizumab for Metastatic Clear Cell Renal Cell Carcinoma

IJU Case Reports, Volume 9, Issue 5, September 2026.
ABSTRACT Introduction Cytokine release syndrome (CRS) is a systemic inflammatory response triggered by various factors, including infection and immunotherapy. Due to its nonspecific presentation, distinguishing CRS from other life‐threatening conditions remains challenging.
Kei Nagase, Hiroaki Kakinoki, Kazuki Nakamura, Yukako Yamaguchi, Shuhei Kusano, Yuka Kakinoki, Maki Kawasaki, Kazuma Udo, Shohei Tobu, Mitsuru Noguchi   +9 more
wiley   +1 more source

Comparative Treatment Strategies for Obstructive Sleep Apnea and Their Relationships with Aberrant Driving Behaviors: Taxi Drivers in Taipei Metropolitan Area. [PDF]

Nat Sci Sleep
Chen Z, Liu WT, Majumdar A, Hsu WH, Kuan YC, Kang JH, Chen YL, Chien R, Wang P, Lee KY, Feng PH, Chen KY, Lee HC, Lin YC, Cheng WH, Tsai CY.   +15 more
europepmc   +1 more source

CPAP treatment for catathrenia

Revista Portuguesa de Pneumologia (English Edition), 2017
C. Dias, L. Sousa, L. Batata, F. Teixeira, J. Moita, J. Moutinho dos Santos   +5 more
openaire   +3 more sources

Risk Analysis Index Versus mFI‐5 for Predicting Outcomes After Uvulopalatopharyngoplasty

The Laryngoscope, Volume 136, Issue 9, Page 3815-3825, September 2026.
This retrospective database study of 2129 adults undergoing uvulopalatopharyngoplasty compared the risk analysis index (RAI) with the modified 5‐item frailty index (mFI‐5) for predicting 30‐day postoperative outcomes and found that frailty was associated with worse morbidity, prolonged hospitalization, non‐home discharge, and mortality.
Akshay Warrier, Ariana Shaari, Aman M. Patel, Christian Bowers, Kenneth Yan   +4 more
wiley   +1 more source

The role of the Baveno classification system in patients with obstructive sleep apnoea. [PDF]

Lung India
Bamagoos AA, Wali SO.
europepmc   +1 more source

The Six Pillars of Lifestyle Medicine in MASLD: An Evidence‐Based Guide

Liver International Communications, Volume 7, Issue 3, September 2026.
ABSTRACT Metabolic dysfunction–associated steatotic liver disease (MASLD) is the most common chronic liver disease worldwide and is projected to affect more than 40% of adults by 2050. Although pharmacologic therapies are emerging, lifestyle modification remains the foundation of management.
Jigyasa Sharma, Kathleen Viveiros
wiley   +1 more source